{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:14:01Z","timestamp":1778260441600,"version":"3.51.4"},"reference-count":73,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573415"],"award-info":[{"award-number":["81573415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872840"],"award-info":[{"award-number":["81872840"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872841"],"award-info":[{"award-number":["81872841"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University Medical-Engineering Cross Fund","doi-asserted-by":"publisher","award":["YG2017ZD14"],"award-info":[{"award-number":["YG2017ZD14"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2019,10,11]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>APOE4 is the strongest genetic risk factor for late-onset Alzheimer\u2019s disease (LOAD). LOAD patients carrying or not carrying APOE4 manifest distinct clinico-pathological characteristics. APOE4 has been shown to play a critical role in the pathogenesis of AD by affecting various aspects of pathological processes. However, the pathogenesis involved in LOAD not-carrying APOE4 remains elusive.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>We aimed to identify the associated genes involved in LOAD not-carrying APOE4.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>An integrated genomic analysis of datasets of genome-wide association study, genome-wide expression profiling and genome-wide linkage scan and protein\u2013protein interaction network construction were applied to identify associated gene clusters in APOE4 non-carriers. The role of one of hub gene of an APOE4 non-carrier-associated gene cluster in tau phosphorylation was studied by knockdown and western blot.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>We identified 12 gene clusters associated with AD APOE4 non-carriers. The hub genes associated with AD in these clusters were MAPK8, POU2F1, XRCC1, PRKCG, EXOC6, VAMP4, SIRT1, MME, NOS1, ABCA1 and LDLR. The associated genes for APOE4 non-carriers were enriched in hereditary disorder, neurological disease and psychological disorders. Moreover, knockdown of PRKCG to reduce the expression of protein kinase C\u03b3 isoform enhanced tau phosphorylation at Thr181 and Thr231 and the expression of glycogen synthase kinase 3\u03b2 and cyclin-dependent kinase 5 in the presence of APOE3 but not APOE4.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The study provides new insight into the mechanism of distinct pathogenesis of LOAD not carrying APOE4 and prompts the functional exploration of identified genes based on APOE genotypes.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1567205016666190823124724","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T06:10:48Z","timestamp":1566799848000},"page":"753-763","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Integrated Genomic Analysis Revealed Associated Genes for Alzheimer\u2019s Disease in APOE4 Non-Carriers"],"prefix":"10.2174","volume":"16","author":[{"given":"Shan","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Chemical Biology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Chemical Biology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Chemical Biology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan-Xue","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Chemical Biology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Zhuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Interdisciplinary Integrative Biomedical Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201210, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Chemical Biology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"Reitz C.","unstructured":"Reitz C.; Mayeux R.; Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 2014,88(4),640-651","journal-title":"Biochem Pharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"Scheltens P","unstructured":"Scheltens P; Blennow K; Breteler MM; de Strooper B4, Frisoni GB5, Salloway S, et alAlzheimer\u2019s disease. Lancet 2016,388(10043),505-517","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.12703\/P7-50","volume":"7","author":"Sindi S.","unstructured":"Sindi S.; Mangialasche F.; Kivipelto M.; Advances in the prevention of Alzheimer\u2019s Disease. F1000Prime Rep 2015,7,50","journal-title":"F1000Prime Rep"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1474-4422(16)00127-7","volume":"15","author":"Cuyvers E.","unstructured":"Cuyvers E.; Sleegers K.; Genetic variations underlying Alzheimer\u2019s disease: evidence from genome-wide association studies and beyond. Lancet Neurol 2016,15(8),857-868","journal-title":"Lancet Neurol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neubiorev.2018.11.007","volume":"96","author":"Wang Z.T.","unstructured":"Wang Z.T.; Tan C.C.; Tan L.; Yu J.T.; Systems biology and gene networks in Alzheimer\u2019s disease. Neurosci Biobehav Rev 2019,96,31-44","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"Corder E.H.","unstructured":"Corder E.H.; Saunders A.M.; Strittmatter W.J.; Schmechel D.E.; Gaskell P.C.; Small G.W.; Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 1993,261(5123),921-923","journal-title":"Science"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1159\/000440714","volume":"5","author":"Suwa A.","unstructured":"Suwa A.; Nishida K.; Utsunomiya K.; Neuropsychological evaluation and cerebral blood flow effects of apolipoprotein e4 in alzheimer\u2019s disease patients after one year of treatment: an exploratory study. Dement Geriatr Cogn Disord Extra 2015,5(3),414-423","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000490739","volume":"77","author":"De Luca V.","unstructured":"De Luca V.; Spalletta G.; Souza R.P.; Graff A.; Bastos-Rodrigues L.; Camargos Bicalho M.A.; Definition of late onset Alzheimer\u2019s disease and anticipation effect of genome-wide significant risk variants: pilot study of the apoe e4 allele. Neuropsychobiology 2019,77(1),8-12","journal-title":"Neuropsychobiology"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1385\/JMN:23:3:157","volume":"23","author":"Ashford J.W.","unstructured":"Ashford J.W.; APOE genotype effects on Alzheimer\u2019s disease onset and epidemiology. J Mol Neurosci 2004,23(3),157-165","journal-title":"J Mol Neurosci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000104467","volume":"24","author":"van der Vlies A.E.","unstructured":"van der Vlies A.E.; Pijnenburg Y.A.; Koene T.; Klein M.; Kok A.; Scheltens P.; Cognitive impairment in Alzheimer\u2019s disease is modified by APOE genotype. Dement Geriatr Cogn Disord 2007,24(2),98-103","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1212\/WNL.46.2.413","volume":"46","author":"Lehtovirta M.","unstructured":"Lehtovirta M.; Soininen H.; Helisalmi S.; Mannermaa A.; Helkala E.L.; Hartikainen P.; Clinical and neuropsychological characteristics in familial and sporadic Alzheimer\u2019s disease: relation to apolipoprotein E polymorphism. Neurology 1996,46(2),413-419","journal-title":"Neurology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1212\/WNL.50.2.355","volume":"50","author":"Smith G.E.","unstructured":"Smith G.E.; Bohac D.L.; Waring S.C.; Kokmen E.; Tangalos E.G.; Ivnik R.J.; Apolipoprotein E genotype influences cognitive \u2018phenotype\u2019 in patients with Alzheimer\u2019s disease but not in healthy control subjects. Neurology 1998,50(2),355-362","journal-title":"Neurology"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1212\/WNL.57.8.1461","volume":"57","author":"Hashimoto M.","unstructured":"Hashimoto M.; Yasuda M.; Tanimukai S.; Matsui M.; Hirono N.; Kazui H.; Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer\u2019s disease. Neurology 2001,57(8),1461-1466","journal-title":"Neurology"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.neuroimage.2009.01.009","volume":"45","author":"Pievani M.","unstructured":"Pievani M.; Rasser P.E.; Galluzzi S.; Benussi L.; Ghidoni R.; Sabattoli F.; Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer\u2019s disease in vivo. Neuroimage 2009,45(4),1090-1098","journal-title":"Neuroimage"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1212\/WNL.53.8.1825","volume":"53","author":"Geroldi C.","unstructured":"Geroldi C.; Pihlajam\u00e4ki M.; Laakso M.P.; DeCarli C.; Beltramello A.; Bianchetti A.; APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 1999,53(8),1825-1832","journal-title":"Neurology"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1073\/pnas.0812697106","volume":"106","author":"Agosta F.","unstructured":"Agosta F.; Vossel K.A.; Miller B.L.; Migliaccio R.; Bonasera S.J.; Filippi M.; Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer\u2019s disease and frontotemporal dementia. Proc Natl Acad Sci USA 2009,106(6),2018-2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3233\/JAD-142556","volume":"45","author":"Wang X.","unstructured":"Wang X.; Wang J.; He Y.; Li H.; Yuan H.; Evans A.; Apolipoprotein E \u03b54 modulates cognitive profiles, hippocampal volume, and resting-state functional connectivity in Alzheimer\u2019s disease. J Alzheimers Dis 2015,45(3),781-795","journal-title":"J Alzheimers Dis"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097608","volume":"9","author":"Manning E.N.","unstructured":"Manning E.N.; Barnes J.; Cash D.M.; Bartlett J.W.; Leung K.K.; Ourselin S.; Alzheimer\u2019s Disease NeuroImaging Initiative. APOE \u03b54 is associated with disproportionate progressive hippocampal atrophy in AD. PLoS One 2014,9(5)","journal-title":"PLoS One"},{"key":"ref=19","first-page":"427","volume":"168","author":"Huang YA","unstructured":"Huang YA; Zhou B; Wernig M; Sudhof TC; ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Abeta Secretion Cell 2017,168(3),427-e21"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"Salloway S.","unstructured":"Salloway S.; Sperling R.; Fox N.C.; Blennow K.; Klunk W.; Raskind M.; Bapineuzumab 301 and 302 Clinical Trial Investigators.Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 2014,370(4),322-333","journal-title":"N Engl J Med"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"Lin YT","unstructured":"Lin YT; Seo J; Gao F; Feldman HM; Wen HL; Penney J; APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types. Neuron 2018,98(6),1141-54 e7","journal-title":"Neuron"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","volume":"32","author":"Hashimoto T.","unstructured":"Hashimoto T.; Serrano-Pozo A.; Hori Y.; Adams K.W.; Takeda S.; Banerji A.O.; Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide. J Neurosci 2012,32(43),15181-15192","journal-title":"J Neurosci"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"Castellano J.M.","unstructured":"Castellano J.M.; Kim J.; Stewart F.R.; Jiang H.; DeMattos R.B.; Patterson B.W.; Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med 2011,3(89)","journal-title":"Sci Transl Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jalz.2015.03.003","volume":"11","author":"Risacher S.L.","unstructured":"Risacher S.L.; Kim S.; Nho K.; Foroud T.; Shen L.; Petersen R.C.; Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). APOE effect on Alzheimer\u2019s disease biomarkers in older adults with significant memory concern. Alzheimers Dement 2015,11(12),1417-1429","journal-title":"Alzheimers Dement"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Shi Y.","unstructured":"Shi Y.; Yamada K.; Liddelow S.A.; Smith S.T.; Zhao L.; Luo W.; Alzheimer\u2019s Disease Neuroimaging Initiative. APOE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 2017,549(7673),523-527","journal-title":"Nature"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","volume":"96","author":"Huynh T.V.","unstructured":"Huynh T.V.; Liao F.; Francis C.M.; Robinson G.O.; Serrano J.R.; Jiang H.; Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of beta-amyloidosis. Neuron 2017,96(5),1013-1023","journal-title":"Neuron"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"Wang C.","unstructured":"Wang C.; Najm R.; Xu Q.; Jeong D.E.; Walker D.; Balestra M.E.; Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med 2018,24(5),647-657","journal-title":"Nat Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"767","DOI":"10.14348\/molcells.2014.0248","volume":"37","author":"Kim J.","unstructured":"Kim J.; Yoon H.; Basak J.; Kim J.; Apolipoprotein E in synaptic plasticity and Alzheimer\u2019s disease: potential cellular and molecular mechanisms. Mol Cells 2014,37(11),767-776","journal-title":"Mol Cells"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"Karch C.M.","unstructured":"Karch C.M.; Goate A.M.; Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 2015,77(1),43-51","journal-title":"Biol Psychiatry"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/omi.2011.0054","volume":"16","author":"Hallock P.","unstructured":"Hallock P.; Thomas M.A.; Integrating the Alzheimer\u2019s disease proteome and transcriptome: a comprehensive network model of a complex disease. OMICS 2012,16(1-2),37-49","journal-title":"OMICS"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13073-016-0355-3","volume":"8","author":"Wang M","unstructured":"Wang M; Roussos P; McKenzie A; Zhou X1, Kajiwara Y, Brennand KJ, et al Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer\u2019s disease. Genome Med 2016,8(1),104","journal-title":"Genome Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.3714","volume":"49","author":"Lotta LA","unstructured":"Lotta LA; Gulati P; Day FR; Payne F3, Ongen H4, van de Bunt M, et al Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet 2017,49(1),17-26","journal-title":"Nat Genet"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1471-2164-15-199","volume":"15","author":"Talwar P.","unstructured":"Talwar P.; Silla Y.; Grover S.; Gupta M.; Agarwal R.; Kushwaha S.; Genomic convergence and network analysis approach to identify candidate genes in Alzheimer\u2019s disease. BMC Genomics 2014,15,199","journal-title":"BMC Genomics"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq513","author":"Saccone SF","unstructured":"Saccone SF; Bolze R; Thomas P; Quan J; Mehta G; Deelman E; SPOT: a web-based tool for using biological databases to prioritize SNPs after a genome-wide association study Nucleic Acids Res 38(Web Server issue): W201-9 2017","journal-title":"SPOT: a web-based tool for using biological databases to prioritize SNPs after a genome-wide association study Nucleic Acids Res 38(Web Server issue): W201-9"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ajhg.2008.02.013","volume":"82","author":"K\u00f6hler S.","unstructured":"K\u00f6hler S.; Bauer S.; Horn D.; Robinson P.N.; Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet 2008,82(4),949-958","journal-title":"Am J Hum Genet"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrg3253","volume":"13","author":"Moreau Y.","unstructured":"Moreau Y.; Tranchevent L.C.; Computational tools for prioritizing candidate genes: boosting disease gene discovery. Nat Rev Genet 2012,13(8),523-536","journal-title":"Nat Rev Genet"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1093\/bioinformatics\/bts581","volume":"28","author":"B\u00f6rnigen D.","unstructured":"B\u00f6rnigen D.; Tranchevent L.C.; Bonachela-Capdevila F.; An unbiased evaluation of gene prioritization tools. Bioinformatics 2012,28(23),3081-3088","journal-title":"Bioinformatics"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/hmg\/ddp120","volume":"18","author":"Baranzini S.E.","unstructured":"Baranzini S.E.; Galwey N.W.; Wang J.; Khankhanian P.; Lindberg R.; Pelletier D.; GeneMSA Consortium. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 2009,18(11),2078-2090","journal-title":"Hum Mol Genet"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.schres.2010.07.001","volume":"122","author":"Jia P.","unstructured":"Jia P.; Wang L.; Meltzer H.Y.; Zhao Z.; Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr Res 2010,122(1-3),38-42","journal-title":"Schizophr Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/bioinformatics\/btm373","volume":"23","author":"Hernandez-Toro J.","unstructured":"Hernandez-Toro J.; Prieto C.; De las Rivas J.; APID2NET: unified interactome graphic analyzer. Bioinformatics 2007,23(18),2495-2497","journal-title":"Bioinformatics"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002375","volume":"8","author":"Khatri P.","unstructured":"Khatri P.; Sirota M.; Butte A.J.; Ten years of pathway analysis: current approaches and outstanding challenges. PLOS Comput Biol 2012,8(2)","journal-title":"PLOS Comput Biol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"15304","DOI":"10.1523\/JNEUROSCI.4255-10.2010","volume":"30","author":"Kam A.Y.","unstructured":"Kam A.Y.; Liao D.; Loh H.H.; Law P.Y.; Morphine induces AMPA receptor internalization in primary hippocampal neurons via calcineurin-dependent dephosphorylation of GluR1 subunits. J Neurosci 2010,30(45),15304-15316","journal-title":"J Neurosci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1523\/JNEUROSCI.4162-03.2004","volume":"24","author":"Lee G.","unstructured":"Lee G.; Thangavel R.; Sharma V.M.; Litersky J.M.; Bhaskar K.; Fang S.M.; Phosphorylation of tau by fyn: implications for Alzheimer\u2019s disease. J Neurosci 2004,24(9),2304-2312","journal-title":"J Neurosci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/01616412.2015.1133485","volume":"38","author":"Zheng B.W.","unstructured":"Zheng B.W.; Yang L.; Dai X.L.; Jiang Z.F.; Huang H.C.; Roles of O-GlcNAcylation on amyloid-\u03b2 precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer\u2019s disease. Neurol Res 2016,38(2),177-186","journal-title":"Neurol Res"},{"key":"ref=45","doi-asserted-by":"publisher","author":"van Rooij J.G.J.","unstructured":"van Rooij J.G.J.; Meeter L.H.H.; Melhem S.; Nijholt D.A.T.; Wong T.H.; Netherlands Brain Bank3,et al. Netherlands Brain Bank. Hippocampal transcriptome profiling combined with protein-protein interaction analysis elucidates Alzheimer\u2019s disease pathways and genes. Neurobiol Aging 74: 225-33 2019","DOI":"10.1016\/j.neurobiolaging.2018.10.023"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2017.06.008","volume":"106","author":"Barbash S.","unstructured":"Barbash S.; Garfinkel B.P.; Maoz R.; Simchovitz A.; Nadorp B.; Guffanti A.; Alzheimer\u2019s brains show inter-related changes in RNA and lipid metabolism. Neurobiol Dis 2017,106,1-13","journal-title":"Neurobiol Dis"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/ana.23870","volume":"74","author":"Liachko N.F.","unstructured":"Liachko N.F.; McMillan P.J.; Guthrie C.R.; Bird T.D.; Leverenz J.B.; Kraemer B.C.; CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration. Ann Neurol 2013,74(1),39-52","journal-title":"Ann Neurol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","volume":"1802","author":"Kim E.K.","unstructured":"Kim E.K.; Choi E.J.; Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 2010,1802(4),396-405","journal-title":"Biochim Biophys Acta"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.1074\/jbc.M110.158477","volume":"286","author":"Ando K.","unstructured":"Ando K.; Uemura K.; Kuzuya A.; Maesako M.; Asada-Utsugi M.; Kubota M.; N-cadherin regulates p38 MAPK signaling via association with JNK-associated leucine zipper protein: implications for neurodegeneration in Alzheimer disease. J Biol Chem 2011,286(9),7619-7628","journal-title":"J Biol Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"20539","DOI":"10.1074\/jbc.M311993200","volume":"279","author":"Bowen R.L.","unstructured":"Bowen R.L.; Verdile G.; Liu T.; Parlow A.F.; Perry G.; Smith M.A.; Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-\u03b2 precursor protein and amyloid-\u03b2 deposition. J Biol Chem 2004,279(19),20539-20545","journal-title":"J Biol Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ana.20433","volume":"57","author":"Taguchi K.","unstructured":"Taguchi K.; Yamagata H.D.; Zhong W.; Kamino K.; Akatsu H.; Hata R.; Identification of hippocampus-related candidate genes for Alzheimer\u2019s disease. Ann Neurol 2005,57(4),585-588","journal-title":"Ann Neurol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10072-007-0744-x","volume":"28","author":"Do\u011fru-Abbaso\u011flu S.","unstructured":"Do\u011fru-Abbaso\u011flu S.; Ayka\u00e7-Toker G.; Hanagasi H.A.; G\u00fcrvit H.; Emre M.; Uysal M.; The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer\u2019s disease. Neurol Sci 2007,28(1),31-34","journal-title":"Neurol Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neulet.2008.07.047","volume":"442","author":"Parildar-Karpuzo\u011flu H.","unstructured":"Parildar-Karpuzo\u011flu H.; Do\u011fru-Abbaso\u011flu S.; Hanagasi H.A.; Karada\u011f B.; G\u00fcrvit H.; Emre M.; Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer\u2019s disease. Neurosci Lett 2008,442(3),287-291","journal-title":"Neurosci Lett"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jns.2010.05.002","volume":"295","author":"Qian Y.","unstructured":"Qian Y.; Chen W.; Wu J.; Tao T.; Bi L.; Xu W.; Association of polymorphism of DNA repair gene XRCC1 with sporadic late-onset Alzheimer\u2019s disease and age of onset in elderly Han Chinese. J Neurol Sci 2010,295(1-2),62-65","journal-title":"J Neurol Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","volume":"68","author":"Bertram L.","unstructured":"Bertram L.; Lill C.M.; Tanzi R.E.; The genetics of Alzheimer disease: back to the future. Neuron 2010,68(2),270-281","journal-title":"Neuron"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000336790","volume":"33","author":"Schmidt C.","unstructured":"Schmidt C.; Wolff M.; von Ahsen N.; Zerr I.; Alzheimer\u2019s disease: genetic polymorphisms and rate of decline. Dement Geriatr Cogn Disord 2012,33(2-3),84-89","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=57","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/729478","volume":"2011","author":"Swaminathan S.","unstructured":"Swaminathan S.; Kim S.; Shen L.; Risacher S.L.; Foroud T.; Pankratz N.; The Alzheimer\u2019s disease neuroimaging initiative adni. genomic copy number analysis in alzheimer\u2019s disease and mild cognitive impairment: an ADNI Study. Int J Alzheimers Dis 2011,2011","journal-title":"Int J Alzheimers Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nn.3067","volume":"15","author":"Raingo J.","unstructured":"Raingo J.; Khvotchev M.; Liu P.; Darios F.; Li Y.C.; Ramirez D.M.; Adachi M.; VAMP4 directs synaptic vesicles to a pool that selectively maintains asynchronous neurotransmission. Nat Neurosci 2012,15(5),738-745","journal-title":"Nat Neurosci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/emmm.201302451","volume":"5","author":"Donmez G.","unstructured":"Donmez G.; Outeiro T.F.; SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol Med 2013,5(3),344-352","journal-title":"EMBO Mol Med"},{"key":"ref=60","first-page":"30","volume":"3","author":"Miners S.","unstructured":"Miners S.; van Helmond Z.; Barker R.; Passmore P.A.; Johnston J.A.; Todd S.; Genetic variation in MME in relation to neprilysin protein and enzyme activity, A\u03b2 levels, and Alzheimer\u2019s disease risk. Int J Mol Epidemiol Genet 2012,3(1),30-38","journal-title":"Int J Mol Epidemiol Genet"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3233\/JAD-2010-101491","volume":"23","author":"Reif A.","unstructured":"Reif A.; Gr\u00fcnblatt E.; Herterich S.; Wichart I.; Rainer M.K.; Jungwirth S.; Association of a functional NOS1 promoter repeat with Alzheimer\u2019s disease in the VITA cohort. J Alzheimers Dis 2011,23(2),327-333","journal-title":"J Alzheimers Dis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fphys.2013.00045","volume":"4","author":"Elali A.","unstructured":"Elali A.; Rivest S.; The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer\u2019s disease. Front Physiol 2013,4,45","journal-title":"Front Physiol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3233\/JAD-131121","volume":"38","author":"Lupton M.K.","unstructured":"Lupton M.K.; Proitsi P.; Lin K.; Hamilton G.; Daniilidou M.; Tsolaki M.; The role of ABCA1 gene sequence variants on risk of Alzheimer\u2019s disease. J Alzheimers Dis 2014,38(4),897-906","journal-title":"J Alzheimers Dis"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mad.2011.11.008","volume":"133","author":"Khalil A.","unstructured":"Khalil A.; Berrougui H.; Pawelec G.; Fulop T.; Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer\u2019s disease. Mech Ageing Dev 2012,133(1),20-29","journal-title":"Mech Ageing Dev"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1326-7-31","volume":"7","author":"Brodeur J.","unstructured":"Brodeur J.; Th\u00e9riault C.; Lessard-Beaudoin M.; Marcil A.; Dahan S.; Lavoie C.; LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking and processing: evidence for a role in Alzheimer\u2019s disease. Mol Neurodegener 2012,7,31","journal-title":"Mol Neurodegener"},{"key":"ref=66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008556","volume":"5","author":"Abisambra J.F.","unstructured":"Abisambra J.F.; Fiorelli T.; Padmanabhan J.; Neame P.; Wefes I.; Potter H.; LDLR expression and localization are altered in mouse and human cell culture models of Alzheimer\u2019s disease. PLoS One 2010,5(1)","journal-title":"PLoS One"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm3151","volume":"12","author":"McMahon H.T.","unstructured":"McMahon H.T.; Boucrot E.; Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 2011,12(8),517-533","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fncel.2013.00281","volume":"7","author":"Menard C.","unstructured":"Menard C.; Bastianetto S.; Quirion R.; Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma. Front Cell Neurosci 2013,7,281","journal-title":"Front Cell Neurosci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1523\/JNEUROSCI.5209-10.2011","volume":"31","author":"Hongpaisan J.","unstructured":"Hongpaisan J.; Sun M.K.; Alkon D.L.; PKC \u03b5 activation prevents synaptic loss, A\u03b2 elevation, and cognitive deficits in Alzheimer\u2019s disease transgenic mice. J Neurosci 2011,31(2),630-643","journal-title":"J Neurosci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1074\/jbc.M112.426536","volume":"288","author":"Corbett G.T.","unstructured":"Corbett G.T.; Roy A.; Pahan K.; Sodium phenylbutyrate enhances astrocytic neurotrophin synthesis via protein kinase C (PKC)-mediated activation of cAMP-response element-binding protein (CREB): implications for Alzheimer disease therapy. J Biol Chem 2013,288(12),8299-8312","journal-title":"J Biol Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","volume":"12","author":"Martin L.","unstructured":"Martin L.; Latypova X.; Wilson C.M.; Magnaudeix A.; Perrin M.L.; Yardin C.; Tau protein kinases: involvement in Alzheimer\u2019s disease. Ageing Res Rev 2013,12(1),289-309","journal-title":"Ageing Res Rev"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1016\/S0021-9258(18)41866-2","volume":"267","author":"Goode N.","unstructured":"Goode N.; Hughes K.; Woodgett J.R.; Parker P.J.; Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol Chem 1992,267(24),16878-16882","journal-title":"J Biol Chem"},{"key":"ref=73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046007","volume":"7","author":"L\u00e9n\u00e1rt N.","unstructured":"L\u00e9n\u00e1rt N.; Szegedi V.; Juh\u00e1sz G.; Kasztner A.; Horv\u00e1th J.; Bereczki E.; Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice. PLoS One 2012,7(9)","journal-title":"PLoS One"}],"container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/174434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T10:57:41Z","timestamp":1610881061000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/174434\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205016666190823124724","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-02-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}